STATISITICAL DESIGN, MONITORING & COORD. OF VISION CLINICAL TRIALS & EPIDEMIOLOGY

统计设计、监测

基本信息

  • 批准号:
    9004297
  • 负责人:
  • 金额:
    $ 589.28万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-11-01 至 2016-10-31
  • 项目状态:
    已结题

项目摘要

This contract is designed to attain extramural support for developing, designing, interpreting, and evaluating clinical trials, epidemiologic and natural history studies. In addition, it will provide for outcomes research involving eye diseases and visual disorders and some preclinical studies. The focus shall be on the design of studies and the collection, analysis, and interpretation of data emanating from these studies, as well as support, and monitoring patient safety and follow-up. Contractor shall also provide analytical and data management support, as described in the work statement, for specified clinical research data bases, cost-effectiveness and economic analyses, quality of life assessment and outcomes research. This will include, but not be limited to, the following areas: analysis of Medicare and other health care databases; evaluation of existing NEI databases such as, centralized NEI Intramural Research database, the Eye Disease Case Control Study, Early Treatment Diabetic Retinopathy Study, Framingham Eye Study, and intramural AIDS and uveitis databases. The 46 active/follow-up trials in 2015 are listed below: For more info: http://clinicalstudies.info.nih.gov/cgi/protinstitute.cgi?NEI.0.html 15-EI-0202: Evaluation of Oral Minocycline in the Treatment of Geographic Atrophy Associated with Age-Related Macular Degeneration * 15-EI-0128: The Genetics of Inherited Eye Disease * 15-EI-0052: Pilot Phase I/II Study of the Evaluation of Interferon Gamma-1b Administered Topically for Macular Edema/Intraretinal Schisis Cysts in Rod-Cone Dystrophy (RCD) and Enhanced S-Cone Syndrome (ESCS) * 15-EI-0041: Patient Expectations When Enrolling in an Early-Phase Clinical Trial * 15-EI-0038: A Phase I/IIa Study of RS1 Ocular Gene Transfer for X-linked Retinoschisis * 15-EI-0020: Adaptive Optics Retinal Imaging * 14-EI-0173: An Investigation of Retinal Findings in Patients with Signs and Symptoms of Alzheimer's Disease Enrolled in 09-M-0198 * 14-EI-0171: The Focal Electro-Oculogram in Macular Disease * 14-EI-0108: Pilot Study to Evaluate Oral Minocycline in the Treatment of Cystoid Macular Edema Associated with Retinitis Pigmentosa * 14-EI-0078: A Phase 2 Multicenter Randomized Clinical Trial of Ciliary Neurotrophic Factor (CNTF) for Macular Telangiectasia Type 2 (MacTel) * 14-EI-0064: Whole Exome and Whole Genome Sequencing for Genotyping of Inherited and Congenital Eye Conditions * 13-EI-0154: Color Vision as an Outcome Measure for Clinical Trials of Inherited Retinal Degenerations * 13-EI-0124: A Pilot Study of Nitisinone in the Treatment of Oculocutaneous Albinism, Type 1B * 13-EI-0072: Microbiome and Ocular Inflammatory Disease * 13-EI-0049: Genetics of Uveal Coloboma * 12-EI-0203: Natural History of ABCA4-Related Retinopathies * 12-EI-0042: NEI Intramural Biorepository for Retinal Diseases * 11-EI-0264: A Pilot Study for the Evaluation of Minocycline as a Microglia Inhibitor in the Treatment of Central Retinal Vein Occlusions * 11-EI-0263: A Pilot Study for the Evaluation of Minocycline as a Microglia Inhibitor in the Treatment of Branch Retinal Vein Occlusions * 11-EI-0245: Generation of Induced Pluripotent Stem (iPS) Cell Lines from Somatic Cells of Participants with Eye Diseases and from Somatic Cells of Matched Controls * 11-EI-0173: The Natural History of Ocular Graft-Versus Host Disease * 11-EI-0147: Longitudinal Investigation of Dark Adaptation in Participants with Age-Related Macular Degeneration * 10-EI-0140: Genotype-Phenotype Study of Patients with Plaquenil -Induced Retinal Toxicity, with Evaluation of the ABCA4 Gene * 10-EI-0093: Immunogenetic Mechanisms in Behcet's Disease * 10-EI-0016: Internal Monitoring of Eye Movement in Schizophrenia * 08-EI-0169: Evaluation and Treatment Protocol for Potential Research Participants with Ocular Diseases * 08-EI-0102: Screening Study for the Evaluation and Diagnosis of Potential Research Participants * 08-EI-0099: Epigenetics, Molecular Genetics, and Biomarkers of Degenerative and Inflammatory Ocular Diseases * 08-EI-0043: Age-Related Eye Disease Study (AREDS) and AREDS2 Follow-Up * 08-EI-0031: Visual Motor Coordination * 06-EI-0236: National Ophthalmic Genotyping and Phenotyping Network, Stage 1 - Creation of DNA Repository for Inherited Ophthalmic Diseases * 06-EI-0068: The Vitreous Proteome and Inflammatory Mediators in Ocular Inflammatory Disease * 06-EI-0059: Clinical and Molecular Studies in Families with Glaucoma and Related Diseases * 06-EI-0058: Clinical and Molecular Studies in Families with Myopia and Related Diseases * 05-EI-0143: Molecular Genetics of Retinal Degenerations * 04-EI-0008: Clinical and Molecular Studies in Families with Corneal Dystrophy or Other Inherited Corneal Diseases * 03-EI-0123: Clinical and Molecular Studies in Families with Congenital or Hereditary Cataracts * 03-EI-0122: Evaluation of Immune Responses to Different Antigens in Non Infectious Ocular Inflammatory Diseases * 03-EI-0033: X-Linked Juvenile Retinoschisis - Clinical and Molecular Studies 13-EI-0206: A Randomized, Controlled, Double-Masked, Clinical Trial of Autologous Serum Eye Drops for Severe Ocular Chronic Graft-versus-Host Disease (GVHD) in Hematopoietic Stem Cell Transplant (HSCT) Patients * 13-EI-0102: Gevokizumab Treatment for Active Scleritis By IL-1 Inhibition (GATSBY) * 12-EI-0167: A Phase I/II Study of the NT-501 Intraocular Implant Releasing Ciliary Neurotrophic Factor (CNTF) in Participants with CNGB3 Achromatopsia * 11-EI-0244: A Pilot Phase I/II Study for the Evaluation of Dextromethorphan as a Microglia Inhibitor in the Treatment of Diabetic Macular Edema (MiDME2) * 07-EI-0213: Laboratory of Immunology/National Eye Institute Repository * 06-EI-0050: Multicenter Uveitis Steroid Treatment (MUST) Trial Protocol * 05-EI-0096: Natural History and Genetic Studies of Usher Syndrome
该合同旨在获得开发、设计、解释和评估临床试验、流行病学和自然历史研究的外部支持。此外,它将提供涉及眼病和视力障碍的结果研究和一些临床前研究。重点应放在研究的设计和收集、分析和解释来自这些研究的数据,以及支持、监测患者的安全性和随访。承包商还应如工作说明书中所述,为指定的临床研究数据库、成本效益和经济分析、生活质量评估和结果研究提供分析和数据管理支持。这将包括但不限于以下领域:对医疗保险和其他卫生保健数据库的分析;评估现有的NEI数据库,如集中的NEI校内研究数据库、眼病病例对照研究、早期治疗糖尿病视网膜病变研究、Framingham眼科研究和校内艾滋病和葡萄膜炎数据库。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KERI HAMMEL其他文献

KERI HAMMEL的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KERI HAMMEL', 18)}}的其他基金

IGF::OT::IGFEMMES NEIS-V
IGF::OT::IGFEMMES NEIS-V
  • 批准号:
    9591728
  • 财政年份:
    2016
  • 资助金额:
    $ 589.28万
  • 项目类别:
IGF::OT::IGFEMMES NEIS-V
IGF::OT::IGFEMMES NEIS-V
  • 批准号:
    9915738
  • 财政年份:
    2016
  • 资助金额:
    $ 589.28万
  • 项目类别:
IGF::OT::IGFEMMES NEIS-V
IGF::OT::IGFEMMES NEIS-V
  • 批准号:
    10074449
  • 财政年份:
    2016
  • 资助金额:
    $ 589.28万
  • 项目类别:
IGF::OT::IGFEMMES NEIS-V
IGF::OT::IGFEMMES NEIS-V
  • 批准号:
    10329834
  • 财政年份:
    2016
  • 资助金额:
    $ 589.28万
  • 项目类别:

相似海外基金

Active couch-potatoes? Combined physical activity-sedentary behaviour associations with weight status in 8-10 year old children
活跃的沙发土豆?
  • 批准号:
    263406
  • 财政年份:
    2012
  • 资助金额:
    $ 589.28万
  • 项目类别:
The Relationship Between Fundamental Motor Skills and Physical Activity in 6-10 year old Children with and without Down syndrome
6-10岁唐氏综合症和非唐氏综合症儿童基本运动技能与体力活动的关系
  • 批准号:
    251607
  • 财政年份:
    2012
  • 资助金额:
    $ 589.28万
  • 项目类别:
    Studentship Programs
BIOPSY AND ANALYSIS OF 5 TO 10 YEAR OLD COMPOSITES
5 至 10 年前复合材料的活检和分析
  • 批准号:
    3221783
  • 财政年份:
    1987
  • 资助金额:
    $ 589.28万
  • 项目类别:
BIOPSY AND ANALYSIS OF 5 TO 10 YEAR OLD COMPOSITES
5 至 10 年前复合材料的活检和分析
  • 批准号:
    3221784
  • 财政年份:
    1987
  • 资助金额:
    $ 589.28万
  • 项目类别:
BIOPSY AND ANALYSIS OF 5 TO 10 YEAR OLD COMPOSITES
5 至 10 年前复合材料的活检和分析
  • 批准号:
    3221782
  • 财政年份:
    1987
  • 资助金额:
    $ 589.28万
  • 项目类别:
PSYCHIATRIC ASSESSMENT OF 5-10 YEAR OLD CHILDREN AT RISK FOR AFFECTIVE DISORDER
对有情感障碍风险的 5-10 岁儿童进行精神病学评估
  • 批准号:
    3968547
  • 财政年份:
  • 资助金额:
    $ 589.28万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了